Læknablaðið : fylgirit - 05.01.2015, Qupperneq 36

Læknablaðið : fylgirit - 05.01.2015, Qupperneq 36
36 LÆKNAblaðið 2011/97 derivatives of the fluorescent labels Rhodamine B and 5-(2-((amino- oxyacetyl)amino)ethylamino)naphthalene-1-sulfonic acid (EDANS-O- NH2). Hydroxylamine derivative of heterobifunctional tetra(ethylene glycol) spacer with protected sulfhydryl group was also synthesized. The hydroxylamine derivatives were reacted to the reducing end of chitosan and glucoseamine with aniline catalysed oxime reaction. The synthesized materials were characterized by NMR and LC-MS measurement. Results: The synthesise of all the hydroxylamine derivatives was suc- cessful. The oxime reaction of glucoseamine with EDANS-O-NH2 and tetra(ethylene glycol) sulfhydryl spacer was successful and was confir- med by NMR and LC-MS. The formation of glucoseamine Rhodamine B product was confirmed by LC-MS. The oxime reaction with EDANS-O- NH2 and chitosan was achieved. Preliminary results from NMR shows that chitosan reducing end reacts with tetra(ethylene glycol) sulfhydryl spacer. Conclusions: These results demonstrates the proof-of-concept for selective oxime formation at the reducing end of a chitosan derivatives, which can be used for tracking chitosan in gene and drug delivery purposes and gives rise to further modifications with other functional groups. E 90 Nýjar N-acyl-dópamín afleiður úr svampdýrinu Myxilla incrustans sem safnað var á Strýtunum í Eyjafirði Eydís Einarsdóttir1, Hongbing Liu1, Helga M. Ögmundsdottir2, Elín S. Ólafsdóttir1, Charlotte H. Gotfredsen3, Sesselja Ómarsdóttir1 1Lyfjafræðideild, 2læknadeild Háskóla Íslands, 3efnafræðideild Tækniháskóla Danmerkur (DTU) eydisei@hi.is Inngangur: Um helmingur allra vestrænna lyfja á rætur sínar að rekja til náttúrunnar. Flest þessara lyfja eru sýkla- og krabbameinslyf. Sjávarlífverur eru ákjósanleg uppspretta lífvirkra efna því umhverfi sjávarlífvera krefst sértækra efna til að komast af í erfiðri lífsbaráttu. Svampdýr eru frumstæðar lífverur og hefur mörg hundruð mismunandi efnasamböndum, s.s. alkalóíðum, pólýketíðum, terpenum, fituefnum og arómatískum efnum, verið lýst. Hafsvæðið í kringum Ísland er einstakt vistkerfi og þar má m.a. finna heitar uppsprettur eins og strýturnar í Eyjafirði. Markmið þessa verkefnis var að safna svampdýrasýnum af Strýtunum, útbúa útdrætti úr þeim og kanna krabbameinshemjandi áhrif þeirra í rækt. Ennfremur að einangra virku efnin og greina sam- eindabyggingu þeirra. Efniviður og aðferðir: 35 svampdýrasýnum var safnað á Strýtunum. Svampdýrin voru frostþurrkuð og síðan úrhlutuð í CH2Cl2:MeOH (1:1) í 24 klst. og leysiefni síðan inngufuð frá. Útdrátturinn var síðan þátt- aður niður með aðlagaðri Kupchan vökvaþáttun í fimm misskautaða þætti (A, BC, D og E). Krabbameinshemjandi áhrif útdrátta og þátta í styrknum 33 µg/mL voru könnuð á SkBr-3 krabbameinsfrumur með MTS aðferð. Einangrun efna var gerð með fastfasasúluskiljun og magn- bundinni háþrýstivökvaskiljun og sameindabygging ákvörðuð með massagreiningu og kjarnsegulgreiningu. Niðurstöður: Átta útdrættir drógu úr lifun krabbameinsfrumanna um meira en helming. Einn þessara útdrátta var úr svampdýrinu Myxilla incrustans. Tveir þættir höfðu einnig frumuhemjandi áhrif. Úr þeim voru einangruð tvo ný efnasambönd sem reyndust vera N-acýl dópamín afleiður með endastæða glúkúronsýru einingu. Ekki er búið að meta krabbameinshemjandi áhrif hreinu efnanna. Ályktanir: Nokkrir útdrættir úr svampdýrum sem safnað var á Strýtunum höfðu krabbameinshemjandi áhrif í rækt. Þar á meðal úr svampdýrinu Myxilla incrustans en fáum efnasamböndum hefur verið lýst úr þessari tegund. Tvær nýjar N-acýl dópamín afleiður með enda- stæðri sykru voru einangraðar og bygging þeirra ákvörðuð. E 91 Quaternary N-alkyl and N,N-dialkyl chitosan derivatives as effective antibacterial agents Priyanka Sahariah1, Berglind E. Benediktssdóttir1, Martha Á. Hjálmarsdóttir2, Ólafur E. Sigurjónsson3,4, Kasper K. Sørensen5, Mikkel B. Thygesen5, Már Másson1 1Faculty of Pharmaceutical Sciences, University of Iceland, 2Department of Biomedical Science, Faculty of Medicine, University of Iceland, 3The REModeL Lab, Blood Bank, Landspítali University Hospital, 4Institute of Biomedical and Neural Engineering, Reykjavík University, 5Department of Chemistry, Faculty of Science, Centre for Carbohydrate Recognition and Signalling, University of Copenhagen prs1@hi.is Introduction: Chitosan a biopolymer, has been modified to obtain qua- ternary N-alkyl derivatives for the development of better antibacterial agents. Methods and data: Chitosan derivatives were characterized using 1H- NMR, COSY and IR spectrum. Molecular weight was determined using GPC. Antibacterial activity was assayed following the CLSI standard protocols against Staphylococcus aureus (ATCC 29213), Enterococcus faecalis(ATCC 29212), Escherichia coli (ATCC 25922)and Pseudomonas aeruginosa (ATCC 27853). Toxicity was determined against human red blood cells. Results: A highly efficient method for the regioselective modi- fication of chitosan biopolymers by means of a simple reductive amination procedure to yield N,N-dialkyl chitosan derivatives was developed using four different alkyl chains. The use of 3,6-O-di-tert- butyldimethylsilylchitosan as a precursor enabled 100% disubstitution of the amino groups. The corresponding mono N-alkyl derivatives were also synthesized, and all the alkyl compounds were then quaternized using an optimized procedure. Antibacterial efficacy against Gram positive S.aureus, E.faecalis and Gram negative E.coli, P.aeruginosa could be correlated to the length of the alkyl chain, but the order of activity was dependent on the bacterial strain. Toxicity against human red blood cells was found to be proportional to the length of the alkyl chain. Derivatives having better selectivity than the quaternary ammonium disinfectants cetylpyridiniumchloride and benzalkoniumchloride as well as the antimicrobial peptides melittin and LL-37 could be obtained. Conclusions: The current work has led to the development of compo- unds having high antibacterial activity and better selectivity. These being less toxic and more biodegradable are a potential alternative to antimicrobial peptides and synthetic antimicrobial polymers. E 92 Stable self-assembled nanoparticles from sulfobutyl-β-cyclodextrin and chitosan for drug delivery Zoltán Fülöp1, Attila Balogh2, Phennapha Saokham1, Þorsteinn Loftsson1 1Faculty of Pharmaceutical Sciences, University of Iceland, 2Department of Organic Chemistry and Technology, Faculty of Chemical Engineering, Budapest University of Technology and Economics zof1@hi.is Introduction: Cyclodextrins are cyclic oligosaccharides with hydrophi- lic surface and lipophilic cavity. They form inclusion complexes with lipophilic molecules, increasing the aqueous solubility of various poorly soluble drugs. Cyclodextrins, their derivatives and their inclusion X V I I V Í S I N D A R Á Ð S T E F N A H Í F Y L G I R I T 8 2
Qupperneq 1
Qupperneq 2
Qupperneq 3
Qupperneq 4
Qupperneq 5
Qupperneq 6
Qupperneq 7
Qupperneq 8
Qupperneq 9
Qupperneq 10
Qupperneq 11
Qupperneq 12
Qupperneq 13
Qupperneq 14
Qupperneq 15
Qupperneq 16
Qupperneq 17
Qupperneq 18
Qupperneq 19
Qupperneq 20
Qupperneq 21
Qupperneq 22
Qupperneq 23
Qupperneq 24
Qupperneq 25
Qupperneq 26
Qupperneq 27
Qupperneq 28
Qupperneq 29
Qupperneq 30
Qupperneq 31
Qupperneq 32
Qupperneq 33
Qupperneq 34
Qupperneq 35
Qupperneq 36
Qupperneq 37
Qupperneq 38
Qupperneq 39
Qupperneq 40
Qupperneq 41
Qupperneq 42
Qupperneq 43
Qupperneq 44
Qupperneq 45
Qupperneq 46
Qupperneq 47
Qupperneq 48
Qupperneq 49
Qupperneq 50
Qupperneq 51
Qupperneq 52
Qupperneq 53
Qupperneq 54
Qupperneq 55
Qupperneq 56
Qupperneq 57
Qupperneq 58
Qupperneq 59
Qupperneq 60
Qupperneq 61
Qupperneq 62
Qupperneq 63
Qupperneq 64
Qupperneq 65
Qupperneq 66
Qupperneq 67
Qupperneq 68
Qupperneq 69
Qupperneq 70
Qupperneq 71
Qupperneq 72
Qupperneq 73
Qupperneq 74
Qupperneq 75
Qupperneq 76
Qupperneq 77
Qupperneq 78
Qupperneq 79
Qupperneq 80
Qupperneq 81
Qupperneq 82
Qupperneq 83
Qupperneq 84
Qupperneq 85
Qupperneq 86
Qupperneq 87
Qupperneq 88
Qupperneq 89
Qupperneq 90
Qupperneq 91
Qupperneq 92
Qupperneq 93
Qupperneq 94
Qupperneq 95
Qupperneq 96
Qupperneq 97
Qupperneq 98
Qupperneq 99
Qupperneq 100
Qupperneq 101
Qupperneq 102
Qupperneq 103
Qupperneq 104
Qupperneq 105
Qupperneq 106
Qupperneq 107
Qupperneq 108
Qupperneq 109
Qupperneq 110
Qupperneq 111
Qupperneq 112
Qupperneq 113
Qupperneq 114
Qupperneq 115
Qupperneq 116
Qupperneq 117
Qupperneq 118
Qupperneq 119
Qupperneq 120
Qupperneq 121
Qupperneq 122
Qupperneq 123
Qupperneq 124
Qupperneq 125
Qupperneq 126
Qupperneq 127
Qupperneq 128
Qupperneq 129
Qupperneq 130
Qupperneq 131
Qupperneq 132
Qupperneq 133
Qupperneq 134
Qupperneq 135
Qupperneq 136
Qupperneq 137
Qupperneq 138
Qupperneq 139
Qupperneq 140
Qupperneq 141
Qupperneq 142
Qupperneq 143
Qupperneq 144
Qupperneq 145
Qupperneq 146
Qupperneq 147
Qupperneq 148
Qupperneq 149
Qupperneq 150
Qupperneq 151
Qupperneq 152
Qupperneq 153
Qupperneq 154
Qupperneq 155
Qupperneq 156
Qupperneq 157
Qupperneq 158
Qupperneq 159
Qupperneq 160
Qupperneq 161
Qupperneq 162
Qupperneq 163
Qupperneq 164
Qupperneq 165
Qupperneq 166
Qupperneq 167
Qupperneq 168
Qupperneq 169
Qupperneq 170
Qupperneq 171
Qupperneq 172
Qupperneq 173

x

Læknablaðið : fylgirit

Direct Links

Hvis du vil linke til denne avis/magasin, skal du bruge disse links:

Link til denne avis/magasin: Læknablaðið : fylgirit
https://timarit.is/publication/991

Link til dette eksemplar:

Link til denne side:

Link til denne artikel:

Venligst ikke link direkte til billeder eller PDfs på Timarit.is, da sådanne webadresser kan ændres uden advarsel. Brug venligst de angivne webadresser for at linke til sitet.